The U.S. Food and Drug Administration (“FDA”) recently issued guidance regarding the use and preservation of personal protective equipment (“PPE”) by 503A sterile compounding pharmacies during the COVID-19 public health emergency. Known as traditional compounding pharmacies, 503A sterile compounding pharmacies generally compound patient-specific prescriptions and are not registered with FDA as Section 503B outsourcing facilities….Read More
FDA Issues Sterile Compounding Pharmacy PPE Guidance
Posted on April 17, 2020 in Health Law News
Published by: Hall Render